Les délégués espèrent trouver un consensus sur la coordination du Plan d’action pour le développement en avril 25/11/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment Lors de négociations informelles tenues vendredi dernier dans la matinée, le Comité du développement et de la propriété intellectuelle semble s’être approché d’un consensus sur le mécanisme de coordination du Plan d’action pour le développement. Cependant, l’après-midi même, les gouvernements ont été incapables de surmonter les divergences qui subsistaient.
Ecuador To Define Its Compulsory Licence Legislation 23/11/2009 by Catherine Saez, Intellectual Property Watch 1 Comment Since Ecuadorean President Rafael Correa signed a decree on 23 October allowing compulsory licences, the national intellectual property office has been working on a mechanism for issuance those licences, which should be studied case by case, according to the national decree.
Delegates Look To April For Consensus On Development Agenda Coordination 20/11/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment Informal negotiations appeared to bring the Committee on Development and Intellectual Property within reach of consensus on a coordination mechanism for the Development Agenda early this morning, but this afternoon governments were unable to overcome remaining differences.
Public Health Roundup: Progress Seen, Investment Needed 18/11/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment New business models might bring down vaccine prices and public-private partnerships could open the way to new treatments to deadly tropical diseases but some countries are lagging behind in their investments to reach their health targets, according to reports from public health organisations holding meetings in different parts of the world.
TRIPS Council Annual Report: Extension Of Health Amendment Deadline Looms Again 18/11/2009 by William New, Intellectual Property Watch Leave a Comment The World Trade Organization General Council, the WTO’s highest-level decision-making body in Geneva, on Tuesday received the annual report for the WTO committee on intellectual property rights. In it were descriptions of the past year’s IP debates and recommendations for extensions of deadlines.
الوصول إلى الدواء الآمن قضية صحة عامة, ليس ملكية فكرية, على حد تعبير المشاركين. 17/11/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment قد تعيق مبادرات مكافحة التزييف الوصول إلى الأدوية لكنها لا تخفف مشكلة العقارات المزيفة، خصوصاً في الدول النامية، وذلك بحسب ما قاله الأعضاء المشاركون في حدث نظم مؤخراً من قبل معهد المجتمع المفتوح.
Brazil Issues Retaliation List Of US Products; IP-Protected Items In Next Round 17/11/2009 by Claudia Jurberg for Intellectual Property Watch Leave a Comment Brazil has announced the list of 222 American products that could suffer retaliation with tariff rates of more than 100 percent of the value when imported to Brazil. The list could be followed by another including potentially hundreds of millions of dollars in non-tariff items related to intellectual property rights such as lower-priced patented pharmaceuticals.
Eduardo Pisani Of Bristol-Myers Squibb Is New IFPMA Director General 10/11/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment The International Federation of Pharmaceutical Manufacturers and Associations has appointed a new director general, Eduardo Pisani, to take office 1 January 2010.
Medicines Access Again Captures Attention At WTO As Progress Urged In Round 30/10/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment Access to medicine and preservation of biodiversity topped the agenda at the World Trade Organization Trade-Related Aspects of Intellectual Property Rights Council meeting this week, as a new alleged drug seizure in France, a concern over a largely-unused amendment to TRIPS intended to help developing countries gain access to medicine, and a renewed mandate on biodiversity at the World Intellectual Property Organization influenced the issues on the table.
Changing Winds For Gene Patenting In the US? Stakeholders React To Draft Report 29/10/2009 by Catherine Saez, Intellectual Property Watch 1 Comment A United States health department advisory group this month produced a new draft report on gene patenting and licensing with recommendations suggesting that excessive patenting can limit patients’ access to gene testing and might not foster genetic research. The recommendations were supported by a variety of health professionals but put the biotechnology industry on edge.